BioAegis Therapeutics, Inc. Email Format

Biotechnology ResearchNew Jersey, United States11-50 Employees

BioAegis Therapeutics, Inc. is a clinical-stage biotechnology company based in North Brunswick, New Jersey, focused on therapies for inflammatory and infectious diseases rooted in plasma gelsolin technology. The company aims to restore levels of plasma gelsolin, a human protein that helps localize inflammation, with deficiency linked to inflammatory dysregulation and severe outcomes such as multiple organ failure and shock. It pursues biomarker-directed treatments across a range of indications to address unmet medical needs.

A record of collaboration and translational development underpins its work, including partnerships with public research institutions to advance gelsolin-based therapies. A recent development noted is a collaboration involving the University of Texas System, reflecting ongoing engagement with major research organizations. Within the biotechnology landscape, BioAegis positions itself as a smaller to mid-sized firm advancing therapies that modulate systemic inflammation and infection.

Get verified BioAegis Therapeutics, Inc. emails free

Company overview Employee directory